InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,616.84
(
-0.32%
)
US TECH 100
18,991.20
(
-1.09%
)
Dow Jones
41,240.52
(
0.16%
)
Brent Oil
80.22
(
-0.06%
)
Bitcoin
62,837.02
(
-0.06%
)
Post# of 252977
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

miljenko

Send PM Follow Ignore
Followers 4
Posts 313
Boards Moderated 0
Alias Born 11/21/2011

miljenko

Re: DewDiligence post# 226951

Monday, 11/18/2019 11:20:51 AM

Monday, November 18, 2019 11:20:51 AM

Post# of 252977
<KarXT is an oral coformulation of xanomeline (a novel muscarinic receptor agonist) and trospium (a muscarinic receptor antagonist) designed to treat psychosis and related symptoms through preferential stimulation of muscarinic receptors in the central nervous system (CNS).>
Agonist + antagonist = ?????
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up